Consensus molecular subtypes and CRCassigner classifications in metastatic colorectal cancer (mCRC): Prognostic and predictive impact in the TRIBE2 study.

Beatrice Borelli,Elisa Fontana,Mirella Giordano,Carlotta Antoniotti,Francesca Bergamo,Sabina Murgioni,Filippo Pietrantonio,Federica Morano,Emiliano Tamburini,Alessandra Boccaccino,Daniele Santini,Veronica Conca,Nicoletta Pella,Evaristo Maiello,Clara Ugolini,Gabriella Fontanini,Alfredo Falcone,Gift Nyamundanda,Anguraj Sadanandam,Chiara Cremolini

Consensus molecular subtypes and CRCassigner classifications in metastatic colorectal cancer (mCRC): Prognostic and predictive impact in the TRIBE2 study.

2020

4016Background: The TRIBE2 study (NCT02339116) recently demonstrated the superiority of upfront FOLFOXIRI/bevacizumab (bev) when compared to a pre-planned strategy of doublets/bev in molecularly un...

Keywords:

Oncology
Colorectal cancer
Pathology
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations